These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18775389)

  • 1. Contraindicated medication use among patients in a memory disorders clinic.
    Barton C; Sklenicka J; Sayegh P; Yaffe K
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):147-52. PubMed ID: 18775389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
    Hutchison LC; Jones SK; West DS; Wei JY
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usage of drugs with potential adverse effects on cognition in a memory-clinic].
    Weih M; Scholz S; Reiss K; Alexopoulos P; Degirmenci U; Richter-Schmidinger T; Kornhuber J
    Fortschr Neurol Psychiatr; 2009 Sep; 77(9):523-7. PubMed ID: 19644785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records.
    Buck MD; Atreja A; Brunker CP; Jain A; Suh TT; Palmer RM; Dorr DA; Harris CM; Wilcox AB
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):84-92. PubMed ID: 19447361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based case-control study of cognitive function in essential tremor.
    Benito-León J; Louis ED; Bermejo-Pareja F;
    Neurology; 2006 Jan; 66(1):69-74. PubMed ID: 16401849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients.
    Barry PJ; O'Keefe N; O'Connor KA; O'Mahony D
    J Clin Pharm Ther; 2006 Dec; 31(6):617-26. PubMed ID: 17176367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter lesion subtypes and cognitive deficits in patients with memory impairment.
    Stenset V; Hofoss D; Berstad AE; Negaard A; Gjerstad L; Fladby T
    Dement Geriatr Cogn Disord; 2008; 26(5):424-31. PubMed ID: 18946220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders.
    Oster G; Berger A; Dukes E; Edelsberg J; McCarberg B
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):163-70. PubMed ID: 15561648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria.
    Gallagher PF; Barry PJ; Ryan C; Hartigan I; O'Mahony D
    Age Ageing; 2008 Jan; 37(1):96-101. PubMed ID: 17933759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types of medication errors in North Carolina nursing homes: a target for quality improvement.
    Hansen RA; Greene SB; Williams CE; Blalock SJ; Crook KD; Akers R; Carey TS
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):52-61. PubMed ID: 16730621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort.
    Freter S; Bergman H; Gold S; Chertkow H; Clarfield AM
    CMAJ; 1998 Sep; 159(6):657-62. PubMed ID: 9780965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of potentially reversible cognitive function disorders in patients of a memory dysfunction clinic].
    Sobów T; Wojtera M; Kłoszewska I
    Psychiatr Pol; 2006; 40(5):845-54. PubMed ID: 17217230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of cholinesterase inhibitor use for dementia.
    Herrmann N; Gill SS; Bell CM; Anderson GM; Bronskill SE; Shulman KI; Fischer HD; Sykora K; Shi HS; Rochon PA
    J Am Geriatr Soc; 2007 Oct; 55(10):1517-23. PubMed ID: 17697100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.